SRPT vs TBI · rev $1.13B vs rev $841.6M
Sarepta Therapeutics Inc (SRPT) versus TrueBlue Inc (TBI) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
TrueBlue Inc (TBI) is a staffing & employment services company listed on NYSE.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported TBI revenue for 2026-06-28 was $841.6M. Net income was -$23.2M. TBI currently screens at market cap $205.8M.
SRPT currently screens at market cap $2.34B. TBI currently screens at market cap $205.8M.
Not investment advice. Open the SRPT and TBI stock pages for the full models.
Not investment advice.